Neogenomics Inc
Laboratory testing company · Fort Myers, Florida, United States · Nasdaq: NEO
Neogenomics Inc is a laboratory testing company headquartered in Fort Myers, Florida, United States. Its shares trade on Nasdaq under the ticker NEO. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2009.
Neogenomics at a glance
What does Neogenomics do?
Operations at its FDA-registered drug sites
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $500,000 sold (2009).
Where is Neogenomics located?
Headquarters: Fort Myers, Florida, United States
- Houston, TexasNeoGenomics, Inc. · FDA drug site
Frequently asked questions about Neogenomics
Where is Neogenomics headquartered?
Neogenomics Inc is headquartered in Fort Myers, Florida, United States.
What does Neogenomics do?
Neogenomics Inc is a laboratory testing company. Its FDA-registered drug sites are registered for analysis. Its SEC industry classification is Services-Testing Laboratories.
Is Neogenomics a public company?
Yes. Neogenomics Inc trades on Nasdaq under the ticker NEO.
Similar companies
- Exact Sciences CorpMadison, Wisconsin, United States
- Guardant Health, Inc.Palo Alto, California, United States
- CareDx, Inc.Brisbane, California, United States
- Biodesix IncLouisville, Colorado, United States
- Dxterity Diagnostics IncCompton, California, United States
- Veracyte, Inc.South San Francisco, California, United States
- Aclarion, Inc.Broomfield, Colorado, United States
- Foundation Medicine, Inc.Cambridge, Massachusetts, United States
Work with CROs and CDMOs like Neogenomics
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences